NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDAlemtuzumab Lemtrada® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDDinutuximab Qarziba® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDGemtuzumab Mylotarg®
(Infusion) 		Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDInotuzumab Besponsa®
(Infusion) 		Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDObinutuzumab Gazyvaro ® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDOfatumumab Arzerra® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
REDRituximab Rixathon®Truxima® Malignant disease and immunosuppression, Anti-lymphocyte monoclonal antibodies, 08.02.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Alemtuzumab Alemtuzumab Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies
Amivantamab Amivantamab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Atezolizumab  Atezolizumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Avelumab  Avelumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
BasiliximabBasiliximab Immune System, Immune System Disorders And Transplantation, Immunosuppressants Monoclonal Antibodies
Belantamab Belantamab Mafodotin [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Belimumab Belimumab Immune System, Immune System Disorders And Transplantation, Immunosuppressants Monoclonal Antibodies
Benralizumab Benralizumab Respiratory System, Airways Disease, Obstructive, Immunosuppressants Monoclonal Antibodies
Bevacizumab Bevacizumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Blinatumomab Blinatumomab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Brentuximab  Brentuximab Vedotin [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
BurosumabBurosumab Nutrition And Metabolic Disorders, Fluid And Electrolyte Imbalances, Phosphate Imbalance, Drugs Affecting Bone Structure And Mineralisation Monoclonal Antibodies
CanakinumabCanakinumab Immune System, Immune System Disorders And Transplantation, Immunosuppressants Monoclonal Antibodies
CanakinumabCanakinumab Musculoskeletal System, Hyperuricaemia And Gout, Immunosuppressants Monoclonal Antibodies
Cemiplimab  Cemiplimab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Cetuximab Cetuximab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Daratumumab  Daratumumab Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Denosumab  Denosumab Endocrine System, Bone Metabolism Disorders, Drugs Affecting Bone Structure And Mineralisation Monoclonal Antibodies
Denosumab  Denosumab Malignant Disease, Secondary Bone Metastases And Hypercalcaemia, Drugs Affecting Bone Structure And Mineralisation Monoclonal Antibodies
Digoxin-Specific Digoxin-Specific Antibody Poisoning, Drug Toxicity, Digoxin Toxicity, Antidotes And Chelators Antibodies
Dinutuximab Dinutuximab Beta [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
DonanemabDonanemab Nervous System, Dementia
Dostarlimab Dostarlimab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Durvalumab Durvalumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Elotuzumab Elotuzumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Elranatamab Elranatamab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Enfortumab  Enfortumab Vedotin [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Epcoritamab Epcoritamab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Gemtuzumab Gemtuzumab Ozogamicin [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Glofitamab Glofitamab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Inotuzumab Inotuzumab Ozogamicin [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Ipilimumab Ipilimumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Isatuximab Isatuximab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
LecanemabLecanemab Nervous System, Dementia
Loncastuximab  Loncastuximab Tesirine [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Mepolizumab Mepolizumab Respiratory System, Airways Disease, Obstructive, Immunosuppressants Monoclonal Antibodies
Mirvetuximab Mirvetuximab Soravtansine [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Mogamulizumab Mogamulizumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Mosunetuzumab Mosunetuzumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Natalizumab Natalizumab Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies
Nivolumab  Nivolumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Nivolumab  Nivolumab With Relatlimab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Obinutuzumab Obinutuzumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Ocrelizumab Ocrelizumab Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies
Ofatumumab Ofatumumab Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies
Omalizumab  Omalizumab Respiratory System, Airways Disease, Obstructive, Immunosuppressants Monoclonal Antibodies
Omalizumab  Omalizumab Skin, Inflammatory Skin Conditions, Urticaria, Immunosuppressants Monoclonal Antibodies
Palivizumab  Palivizumab Anti-Infective, Viral Infection, Respiratory Syncytial Virus, Drugs For Respiratory Diseases Monoclonal Antibodies
Panitumumab Panitumumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Pembrolizumab Pembrolizumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Pertuzumab Pertuzumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Pertuzumab Pertuzumab With Trastuzumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Polatuzumab  Polatuzumab Vedotin [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Ramucirumab Ramucirumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Reslizumab Reslizumab Respiratory System, Airways Disease, Obstructive, Immunosuppressants Monoclonal Antibodies
Rituximab  Rituximab Immune System, Immune System Disorders And Transplantation, Antineoplastic Drugs Monoclonal Antibodies
Rituximab  Rituximab Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Rituximab  Rituximab Musculoskeletal System, Arthritis, Antineoplastic Drugs Monoclonal Antibodies
Romosozumab Romosozumab Endocrine System, Bone Metabolism Disorders, Drugs Affecting Bone Structure And Mineralisation Monoclonal Antibodies
RozanolixizumabRozanolixizumab Musculoskeletal System, Neuromuscular Disorders, Myasthenia Gravis And Lambert-Eaton Myasthenic Syndrome, Immunosuppressants Monoclonal Antibodies
Sacituzumab  Sacituzumab Govitecan [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
SiltuximabSiltuximab Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Sotrovimab  Sotrovimab Anti-Infective, Viral Infection, Coronavirus, Antivirals SARS-Cov-2 Neutralising Monoclonal Antibodies
Tafasitamab Tafasitamab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Talquetamab Talquetamab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Teclistamab Teclistamab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Tezepelumab Tezepelumab Respiratory System, Airways Disease, Obstructive, Immunosuppressants Monoclonal Antibodies
Trastuzumab Trastuzumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Trastuzumab Trastuzumab Deruxtecan [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Trastuzumab Trastuzumab Emtansine [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Tremelimumab Tremelimumab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Ublituximab Ublituximab Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies
Vedolizumab Vedolizumab Gastro-Intestinal System, Chronic Bowel Disorders, Inflammatory Bowel Disease, Immunosuppressants Monoclonal Antibodies
Zolbetuximab Zolbetuximab [Specialist Drug] Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.